HK Stock MarketDetailed Quotes

03347 TIGERMED

Watchlist
  • 30.800
  • -0.300-0.96%
Market Closed Dec 31 12:08 CST
26.64BMarket Cap25.02P/E (TTM)

TIGERMED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TIGERMED Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 28, 20252024/Q4-- / 2.068B--
Oct 29, 20242024/Q31.709B / 2.163B--
Aug 28, 20242024/Q21.698B / 2.092B--
Mar 28, 20242023/Q41.734B / 2.012B--
Oct 27, 20232023/Q31.940B / 1.965B--
DatePeriodRevenue/EstimateEarnings Call
Mar 28, 20252024/Q4-- / 2.068B--
Oct 29, 20242024/Q31.709B / 2.163B--
Aug 28, 20242024/Q21.698B / 2.092B--
Mar 28, 20242023/Q41.734B / 2.012B--
Oct 27, 20232023/Q31.940B / 1.965B--

Unlock Free Earnings Estimates

TIGERMED Earnings Reports

  • TIGERMED: 2024 THIRD QUARTERLY REPORT

    Oct 29, 2024 04:30 ET

  • TIGERMED: DATE OF BOARD MEETING

    Oct 17, 2024 05:28 ET

  • TIGERMED: 2024 INTERIM REPORT

    Sep 27, 2024 04:52 ET

  • TIGERMED: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024

    Aug 28, 2024 06:13 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Biotechnology
    Biotechnology
    Intraday-0.31%
    CRO
    CRO
    Intraday-0.40%